U.S. black women have lower breast cancer survival

	Tweet

Black women with early-stage breast cancer have lower survival rates than their white counterparts even after taking into account variables such as tumor size and socioeconomic differences, researchers said.

“I think it’s due to biological factors in the actual cancer, and this means that race may be a surrogate for a more adverse molecular profile within the cancer,” said Dr. Kathy Albain, the study’s senior researcher and a professor of medicine at Loyola University Chicago Medical Center.

The study, conducted by the Committee on Special Populations of the Southwest Oncology Group that Albain chairs, used databases from two national clinical trials done in the early 1990s.

It matched 317 pairs of women—317 black and 317 white—who had been treated for early-stage breast cancer with chemotherapy and who had been followed after treatment over 10 years.

The survival rate of the white women after 10 years was 86 percent compared to 76 percent for the black women.

All the women had the same tumor stage and were treated identically. The potential influence of age, tumor differences, education level and socioeconomic status also was considered.

The study then took into account the fact that black women were more likely to have discontinued treatment early, to have missed appointments or delayed treatment and had lower initial white blood cell counts. But they had the same relative doses of total chemotherapy delivered during treatment.

Even after adjusting for all of these variables, the survival rate of black women remained worse.

“What we learned is that treatment factors do not explain the racial disparities in survival outcome for early breast cancer,” Albain told Reuters in a telephone interview.

She said the study highlights the need for research into the genetic makeup of tumors for each patient, and for tailoring treatments to fight more aggressive cancers.

The study was presented late on Friday at the 29th annual San Antonio Breast Cancer Symposium.

RELATED STORIES:
Why women quit breast cancer drugs early   Breast Cancer Experts Available for Comment   Common Genetic Mutation in Breast Cancer May Point to New Treatments for Heart Disease   Breast cancer regimen linked to cognitive decline   Mammograms saved lives of women under 50: study   Parsley, Celery Carry Crucial Component for Fight Against Breast Cancer, MU Researcher Finds   Smaller Breast Reduction Surgeries Provide Health Benefits and Should Be Reimbursed   Princess Margaret Hospital Breast Cancer Researchers Link Ovarian Hormone to Breast Stem Cells Growth   Targeted breast ultrasound can reduce biopsies for women under 40   Breast self-exams do not appear to reduce breast cancer deaths   Wine May Provide Radioprotective Effect for Breast Cancer Patients   A novel therapeutic target to slow breast cancer cell motility   Clodronate does not improve breast cancer survival   Radiation After Mastectomy Improves Breast Cancer Survival   Integrating genetic information with breast cancer risk factors may help refine prognosis   Chemotherapy and tamoxifen reduce risk of second breast cancer   Scientists Discover Cancer-causing Role of Gene Proteins   Norwegian research questions benefit of mammograms   New Dubin Breast Center at Mount Sinai Raises the Standard for Comprehensive Cancer Care   Lasers Illuminate Women’s Health in inaugural open-access journal Biomedical Optics Express   Antibiotic Slows Growth of Bladder, Breast Cancer Cells   New mammography technology improves cancer detection

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]